IGF-1 decreases collagen degradation in diabetic NOD mesangial cells: Implications for diabetic nephropathy

Diabetes

Volumn 48, Issue 8, 1999, Pages 1638-1644

  Lupia, Enrico ^a   Elliot, Sharon J ^a   Lenz, Oliver ^a   Zheng, Feng ^a   Hattori, Masakazu ^b   Striker, Gary E ^a   Striker, Liliane J ^a  

^a UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^b JOSLIN DIABETES CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; GELATINASE A; GELATINASE B; SOMATOMEDIN C;

ANIMAL CELL; ARTICLE; COLLAGEN DEGRADATION; COLLAGEN METABOLISM; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC NEPHROPATHY; EXTRACELLULAR MATRIX; GLOMERULOSCLEROSIS; MESANGIUM CELL; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL;

ANIMALS; CELLS, CULTURED; COLLAGEN; COLLAGENASES; DIABETES MELLITUS, TYPE 1; DIABETIC NEPHROPATHIES; FEMALE; GELATINASES; GLOMERULAR MESANGIUM; GLOMERULOSCLEROSIS, FOCAL SEGMENTAL; HUMANS; INSULIN-LIKE GROWTH FACTOR I; LAMININ; MATRIX METALLOPROTEINASE 2; MATRIX METALLOPROTEINASE 9; METALLOENDOPEPTIDASES; MICE; MICE, INBRED NOD; RNA, MESSENGER; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0032785644     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.48.8.1638     Document Type: Article

References (48)

1. Morel-Maroger Striker L, Killen P, Chi E, Striker GE: The composition of glomerulosclerosis: studies in focal sclerosis, crescentic glomerulosclerosis, and membranoproliferative glomerulonephritis. Lab Invest 51:181-192, 1984
2. Adler S, Striker LJ, Striker GE, Perkinson DT, Hibbert J, Couser WG: Studies on progressive glomerular sclerosis in the rat. Am J Pathol 123:553-562, 1986
3. Steffes MW, Osterby R, Chavers B, Mauer SM: Mesangial expansion as a central mechanism for loss of kidney function in diabetic patients. Diabetes 38:1077-1081, 1989
4. Striker LJ, Doi T, Elliot SJ, Striker GE: The contribution of glomerular mesangial cells to progressive glomerulosclerosis. Semin Nephrol 9:318-328, 1989
5. Tochino Y: The NOD mouse as a model of type I diabetes. Crit Rev Immunol 8:49-81, 1987
6. Doi T, Hattori M, Agodoa LY, Sato T, Yoshida H, Striker LJ, Striker GE: Glomerular lesions in nonobese diabetic mouse: before and after the onset of hyperglycemia. Lab Invest 63:204-212, 1990
7. Yang CW, Hattori M, Vlassara H, He CJ, Carome MA, Yamato E, Elliot SJ, Striker GE, Striker LJ: Overexpression of transforming growth factor-β1 is associated with up-regulation of glomerular tenascin and laminin gene expression in nonobese diabetic mice. J Am Soc Nephrol 5:1610-1617, 1995
8. Segev Y, Landau D, Marbach M, Shehadeh N, Flyvbjerg A, Phillip M: Renal hypertrophy in hyperglycemic non-obese diabetic mice is associated with persistent renal accumulation of insulin-like growth factor-I. J Am Soc Nephrol 8:436-444, 1997
9. Elliot SJ, Striker LJ, Hattori M, Yang CW, He CJ, Peten EP, Striker GE: Mesangial cells from diabetic NOD mice constitutively secrete increased amounts of insulin-like growth factor-I. Endocrinology 133:1783-1788, 1993
10. Roy S, Sala R, Cagliero E, Lorenzi M: Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc Natl Acad Sci U S A 87:404-408, 1990
11. Mecham RP, Whitehouse LA, Wrenn DS, Parks WC, Griffin GL, Senior RM, Crouch EC, Stenmark KR, Voelkel NF: Smooth muscle-mediated connective tissue remodeling in pulmonary hypertension. Science 237:423-426, 1987
12. Jacot TA, Striker GE, Stetler-Stevenson MA, Striker LJ: Mesangial cells from transgenic mice with progressive glomerulosclerosis exhibit stable, phenotypic changes including undetectable MMP-9 and increased type IV collagen. Lab Invest 75:791-799, 1996
13. Pugliese F, Ferrario RG, Ciavolella A, Tamburin M, Benatti L, Casini A, Patrono C, Salvati P: Growth abnormalities in cultured mesangial cells from rats with spontaneous glomerulosclerosis. Kidney Int 47:106-113, 1995
14. Trevisan R, Yip J, Sarika L, Kuen Li L, Viberti G: Enhanced collagen synthesis in cultured skin fibroblasts from insulin-dependent diabetic patients with nephropathy. J Am Soc Nephrol 8:1133-1139, 1997
15. Striker GE, He CJ, Liu ZH, Yang DCW, Zalups RK, Esposito C, Striker LJ: Patho genesis of nonimmune glomerulosclerosis: studies in animals and potential applications to humans. Lab Invest 73:569-605, 1995
16. Heidland A, Sebekova K, Paczek L, Tescner M, Dammrich J, Gaciong Z: Renal fibrosis: role of impaired proteolysis and potential therapeutic strategies. Kidney Int 52 (Suppl. 62):S32-S35, 1997
17. MacKay K, Striker LJ, Elliot SJ, Pinkert CA, Brinster RL, Striker GE: Glomerular epithelial, mesangial, and endothelial cell lines from transgenic mice. Kidney Int 33:677-684, 1988
18. Oliver GW, Leferson JD, Stetler-Stevenson WG, Kleiner DE: Quantitative reverse zymography: analysis of picogram amounts of metalloproteinase inhibitors using gelatinase A and B reverse zymograms. Anal Biochem 244:161-166, 1997
19. 2 exposure. Lab Invest 77:533-539, 1997
20. Carome MA, Striker LJ, Peten EP, Elliot SJ, Yang CW, Stetler-Stevenson WG, Reponen P, Tryggvason K, Striker GE: Assessment of 72-kilodalton gelatinase and TIMP-1 gene expression in normal and sclerotic murine glomeruli. J Am Soc Nephrol 5:1391-1399, 1994
21. Liotta LA, Steeg PS, Stetler-Stevenson WG: Cancer metastasis and angiogenesis: an imbalance of positive and negative regulation. Cell 64:327-336, 1991
22. Matrisian LM: Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 6:121-125, 1990
23. Birkedal-Hansen H: Proteolytic remodeling of extracellular matrix. Curr Opin Cell Biol 7:728-735, 1995
24. Woessner JF: Matrix metalloproteinases and their inhibitors in connective tissue remodeling. FASEB J 5:2145-2154, 1991
25. Conway JG, Wakefield JA, Brown RH, Marron BE, Sekut L, Stimpson SA, McElroy A, Menius JA, Jeffreys JJ, Clark RL, McGeehan GM, Connolly KM: Inhibition of cartilage and bone destruction in adjuvant arthritis in the rat by a matrix metalloproteinase inhibitor. J Exp Med 182:449-457, 1995
26. Gijbels K, Galdary RE, Steinmann L: Reversal of experimental autoimmune encephalomyelitis with a hydroxamate inhibitor of matrix metalloproteinases. J Clin Invest 84:678-685, 1994
27. Marti HP, McNeil L, Thomas G, Davies M, Lovett DH: Molecular characterization of a low molecular-mass matrix metalloproteinase secreted by glomerular mesangial cells as Pump-1. Biochem J 285:899-905, 1992
28. Suzuki D, Miyazaki M, Jinde K, Koji T, Yagame M, Endoh M, Nomoto Y, Sakai H: In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type IV collagen in diabetic nephropathy. Kidney Int 52:111-119, 1997
29. Teschner M, Schaefer RM, Svarnas A, Heidland U, Heidland A: Decreased proteinase activity in isolated glomeruli of streptozotocin diabetic rats. Am J Nephrol 9:464-469, 1989
30. Reckelhoff JF, Tygart VL, Mitias Walcott JL: STZ-induced diabetes results in decreased activity of glomerular cathepsin and metalloproteinase in rats. Diabetes 42:1425-1432, 1993
31. Reckelhoff JF, Tygart VL, Racusen LC, Dzielak DJ: Glomerular metalloproteinase activity in streptozotocin-treated rats and in spontaneously diabetic rats (BB/DP). Life Sci 55:941-950, 1994
32. Marti HP, McNeil L, Davies M, Martin J, Lovett DH: Homology cloning of rat 72 kD type IV collagenase: cytokine and second messenger inducibility in glomerular mesangial cells. Biochem J 291:441-446, 1993
33. Martin J, Knowlden J, Davies M, Williams JD: Identification and independent regulation of human mesangial cell metalloproteinases. Kidney Int 46: 877-885, 1994
34. Leehey DJ, Song RH, Alavi N, Singh AK: Decreased degradative enzymes in mesangial cells cultured in high glucose media. Diabetes 44:929-935, 1995
35. Caenazzo C, Garbisa S, Onisto M, Zampieri M, Baggio B, Gambaro G: Effect of glucose and heparin on mesangial α1(IV) COLL and MMP-2/TIMP-2 mRNA expression. Nephrol Dial Transplant 12:443-448, 1997
36. Huhtala P, Chow L, Tryggvason K: Structure of the human type IV collagenase gene. J Biol Chem 265:11077-11082, 1990
37. Huhtala P, Tuuttila A, Chow L, Lohi J, Keski-Oja J, Tryggvason K: Complete structure for gene of the 92 kD collagenase. J Biol Chem 266:16485-16490, 1991
38. Matsubara M, Girard MT, Kublin CL, Cintron C, Fini E: Differential roles for two gelatinolytic enzymes of the matrix metalloproteinase family in the remodeling cornea. Dev Biol 147:425-439, 1991
39. Salo T, Makela M, Kylmaniemi M, Autio-Harmainen H, Larjava H: Expression of matrix metalloproteinase-2 and -9 during early human wound healing. Lab Invest 70:176-182, 1994
40. Canalis E, Rydziel S, Delany AM, Varghese S, Jeffrey JJ: Insulin-like growth factors inhibit interstitial collagenase synthesis in bone cell cultures. Endocrinology 136:1348-1354, 1995
41. Ghazary A, Shen YL, Nedelec B, Wang R, Scott PG, Tredget EE: Collagenase production is lower in post-burn hypertrophic scar fibroblasts than in normal fibroblasts and is reduced by insulin-like growth factor-1. J Invest Dermatol 106:476-481, 1996
42. Flyvbjerg A: Role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in the renal complications of diabetes. Kidney Int 52 (Suppl. 60):S12-S19, 1997
43. Hirschberg R, Adler S: Insulin-like growth factor system and the kidney: physiology, pathophysiology, and therapeutic implications. Am J Kidney Dis 31: 901-919, 1998
44. Flyvbjerg A, Thorlacius-Ussing O, Nœraa R, Ingerslev J, Ørskov H: Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rate. Diabetologia 31:310-314, 1988
45. Cummings EA, Sochett EB, Dekker MG, Lawson ML, Daneman D: Contribution of growth hormone and IGF-1 to early diabetic nephropathy in type I diabetes. Diabetes 47:1341-1346, 1998
46. Flyvbjerg A, Bornfeldt KE, Marshall SM, Amqvist HJ, Ørskov H: Kidney IGF-1 mRNA in initial renal hypertrophy in experimental diabetes in rats. Diabetologia 33:335-338, 1990
47. Landau D, Chin E, Bondy C, Domene H, Roberts CT Jr, Grønbœk H, Flyvbjerg A, LeRoith D: Expression of insulin-like growth factor binding proteins in the rat kidney: effects of long-term diabetes. Endocrinology 136:1835-1842, 1995
48. Flyvbjerg A, Landau D, Domene H, Hernandez L, Grønbœk H, LeRoith D: The role of growth hormone, insulin-like growth factors (IGFs) and IGF-binding proteins in experimental diabetic kidney disease. Metabolism 44:67-71, 1995